Scinai Immunotherapeutics (SCNI) Other Non-Current Assets (2016 - 2025)

Scinai Immunotherapeutics has disclosed Other Non-Current Assets across 10 years of filings, most recently posting $150000.0 for Q4 2025.

• Other Non-Current Assets for Q4 2025 came in at $150000.0, up 14.5% year-over-year; the trailing twelve-month figure through Dec 2025 was $150000.0 (up 14.5% YoY), and the FY2025 annual result was $150000.0, up 14.5% from the prior year.
• Other Non-Current Assets came in at $150000.0 for Q4 2025 at Scinai Immunotherapeutics, up from $131000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $437.0 million in Q2 2021 to a low of $127000.0 in Q1 2023.
• The 5-year median for Other Non-Current Assets is $140000.0 (2022), against an average of $72.9 million.
• Across the five-year window, Other Non-Current Assets slumped 99.97% in 2021 and rose 14.5% in 2025, its largest moves.
• Scinai Immunotherapeutics' Other Non-Current Assets stood at $143000.0 in 2021, then fell by 2.1% to $140000.0 in 2022, then changed by 0.0% to $140000.0 in 2023, then fell by 6.43% to $131000.0 in 2024, then gained by 14.5% to $150000.0 in 2025.
• The last three Other Non-Current Assets figures came in at $150000.0 (Q4 2025), $131000.0 (Q4 2024), and $140000.0 (Q4 2023), per Business Quant data.